Stock Earnings

Question 1

WAVE Life Sciences Ltdの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、WAVE Life Sciences Ltdの総資産は$352で、純lossは$-97です。

Question 2

WVEの主要な財務比率は何ですか？

Accepted Answer

WAVE Life Sciences Ltdの流動比率は2.62、純利益率は-89.81、1株当たり売上高は$0.78です。

Question 3

WAVE Life Sciences Ltdの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

WAVE Life Sciences Ltd largest revenue segment is Stereopure Oligonucleotides, at a revenue of 113,305,000 in the most earnings release.For geography, Singapore, United States, Japan, United Kingdom, and Ireland is the primary market for WAVE Life Sciences Ltd, at a revenue of 113,305,000.

Question 4

WAVE Life Sciences Ltdは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、WAVE Life Sciences Ltdの純lossは$-97です。

Question 5

WAVE Life Sciences Ltdに負債はありますか？

Accepted Answer

yes、WAVE Life Sciences Ltdの負債は134です。

Question 6

WAVE Life Sciences Ltdの発行済株式数は何株ですか？

Accepted Answer

WAVE Life Sciences Ltdの総発行済株式数は153.03株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	93	108	113	3	40	20
Revenue Growth (YoY)	-15%	-4%	3,667%	-93%	100%	33%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	67	59	51	50	46	42
Research & Development	169	159	130	115	121	130
Operating Expenses	237	218	181	166	167	173
Other Non Operating Income (Expenses)	2	3	1	0	4	2
Pretax Income	-129	-97	-58	-161	-122	-150
Income Tax Expense	0	0	0	0	0	0
Net Income	-129	-97	-57	-161	-122	-149
Net Income Growth	77%	70%	-65%	32%	-18%	-23%
Shares Outstanding (Diluted)	163.98	138.27	106.09	78.86	51.83	39.23
Shares Change (YoY)	27%	30%	35%	52%	32%	16%
EPS (Diluted)	-0.79	-0.7	-0.54	-2.05	-2.36	-3.82
EPS Growth	37%	28.99%	-74%	-13%	-38%	-33%
Free Cash Flow	-200	-151	-20	-129	-89	-117
Free Cash Flow Per Share	-1.21	-1.09	-0.18	-1.63	-1.71	-2.98
Gross Margin	--	--	--	--	--	--
Operating Margin	-153.76%	-101.85%	-59.29%	-5,400%	-317.5%	-765%
Profit Margin	-138.7%	-89.81%	-50.44%	-5,366.66%	-305%	-745%
Free Cash Flow Margin	-215.05%	-139.81%	-17.69%	-4,300%	-222.5%	-585%
EBITDA	-140	-107	-62	-156	-120	-145
EBITDA Margin	-150.53%	-99.07%	-54.86%	-5,200%	-300%	-725%
D&A For EBITDA	3	3	5	6	7	8
EBIT	-143	-110	-67	-162	-127	-153
EBIT Margin	-153.76%	-101.85%	-59.29%	-5,400%	-317.5%	-765%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

WAVE Life Sciences Ltd (WVE) Price

WVE Stock Price Chart

WVE Income

Follow-Up Questions